Frankincense and Myrrh Arthritis Pain Therapy

Description

Frankincense and Myrrh is a topical analgesic lotion formulated for pain therapy associated with arthritis. This product is designed to provide fast-acting relief for joint and muscle discomfort. Each application delivers a moisturizing repair effect, enhancing skin hydration while targeting areas of pain. The formulation includes 1.3% menthol, which contributes to its analgesic properties. The lotion is packaged in a net weight of 3 oz (85 g).

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with arthritis.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended application is to the affected area no more than 3 to 4 times daily. It is important to ensure that the application is performed gently and that the affected area is clean and dry prior to use.

For children under 12 years of age, it is advised to consult a healthcare professional before use to determine the appropriate course of action.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied to wounds or damaged skin due to the potential for irritation and impaired healing. Additionally, application over large areas of the body is contraindicated to prevent systemic absorption and potential adverse effects. Contact with the eyes must be avoided to prevent irritation or injury. Furthermore, tight bandaging of the area where the product is applied is not recommended, as it may lead to increased local pressure and potential complications.

Warnings and Precautions

This product is intended for external use only. It is imperative that healthcare professionals advise patients against applying the product on wounds or damaged skin, as well as over large areas of the body, to prevent adverse effects.

During the application of this product, it is crucial to avoid contact with the eyes. Additionally, patients should be instructed not to bandage the area tightly, as this may lead to complications.

Healthcare professionals should counsel patients to discontinue use and seek medical advice if any of the following occur: the condition worsens, irritation develops, or symptoms persist for more than 7 days. If symptoms resolve and then recur within a few days, medical consultation is also recommended.

It is essential to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It should not be applied to wounds or damaged skin, nor should it be used over large areas of the body. During use, it is important to avoid contact with the eyes and to refrain from tightly bandaging the area of application.

Participants are advised to discontinue use and consult a healthcare professional if the condition worsens, if irritation occurs, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

For individuals who are pregnant or breastfeeding, it is recommended to seek advice from a health professional prior to use. Additionally, this product should be kept out of reach of children; if swallowed, immediate medical assistance should be sought or contact with a Poison Control Center should be made without delay.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Frankincense and Myrrh Arthritis Pain Therapy (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended application is to the affected area no more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and breastfeeding infants are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with a healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential.

Management procedures should include monitoring vital signs and providing supportive care as needed. In cases where the specific substance is known, appropriate antidotes or treatments should be administered as per established protocols.

It is vital for healthcare providers to remain vigilant and act swiftly to mitigate the potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of the reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed not to use the product on wounds or damaged skin, and to avoid applying it over large areas of the body. It is important for patients to stop using the product and consult a doctor if their condition worsens, if irritation occurs, or if symptoms persist for more than 7 days. Additionally, patients should be informed that if symptoms clear up and then recur within a few days, they should also seek medical advice.

While using this product, patients must be cautioned to avoid contact with the eyes. Furthermore, they should be advised not to bandage the area tightly after application to ensure proper use and minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a tamper-resistant container. It is essential to inspect the seal under the tube cap prior to use; do not use the product if the seal is broken or missing.

For optimal storage, the product should be kept in a cool, dry place to maintain its integrity and effectiveness.

Additional Clinical Information

Patients aged 12 years and older are advised to apply the medication to the affected area no more than 3 to 4 times daily. For children under 12 years of age, it is recommended to consult a doctor regarding the appropriate use and administration of the product. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Frankincense and Myrrh Arthritis Pain Therapy, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)